Skip to main content

Table 1 Patient characteristics

From: Innovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer

  Group IT (n = 9) Group SA (n = 6)
Age, median (range) 66 (57–75) 77 (63–90)
Gender Male Male
Histological cell type   
Squamous cell carcinoma 6 1
Adenocarcinoma 3 4
Large cell carcinoma 0 1
Clinical stage   
1 0 4
2 0 2
3 9 0
T1aN2 1  
T2bN2 3  
T3N1 3  
T3N2 2  
Pathological stage*   
0 4 0
1 2 4
2 0 2
3 3 0
T1aN2 1  
T1bN2 1  
T3N1 1  
Pathological effect   
Complete response 4 -
Major response 4 -
Minor response 1 -
Operative procedure   
Lobectomy** 6 6
Pneumonectomy 3 0
  1. Abbreviations: IT Induction chemoradiotherapy followed by surgery, SA Surgery alone.
  2. *Pathological stage means post-therapeutic stage (yp–stage) in the IT group.
  3. **Lobectomy, including bilobectomy and lobectomy with bronchoplasty/angioplasty.